Natera, Inc. (NTRA) financial statements and ratios from SEC XBRL: revenue $2.7B (TTM), net margin -9.0%, revenue growth 37.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $2.31B |
| Revenue (TTM) | $2.7B |
| Net Margin | -9.0% |
| Operating Margin (TTM) | -10.7% |
| Net Debt / EBITDA | 4.2 |
| Revenue Growth (YoY) | 37.7% |
| EPS Growth (YoY) | -36.5% |
| FCF Growth (YoY) | -174.0% |
| Price / Book | 26.64 |
| Price / Sales | 17.93 |
| FCF Yield | 0.2% |
| Altman Z-Score | 41.18 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
NTRA overview · NTRA earnings · NTRA KPIs · NTRA documents · NTRA ownership · NTRA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.